Recurrent Wheezing clinical trials

Explore recruiting recurrent wheezing clinical trials.

Recruiting recurrent wheezing studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Recurrent Wheezing trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess the Efficacy and Safety of Daily OM-85 Treatment vs. Placebo given in Children Aged 6 Months to 5 Years with Recurrent Wheezing

Hungary, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Innovative Steroid Treatment to Reduce Asthma Development in Children After First-time Rhinovirus Induced Wheezing - The INSTAR study

Finland, Sweden, Norway

Therapeutic use (Phase IV) EU CTIS Study details

Randomized, multicenter, open-label study on PREvention of respiratory SEquelae of RSV bronchiolitis in preterm babies (PRESERV)

Italy

Therapeutic confirmatory (Phase III) EU CTIS Study details

Recurrent Wheezing trials by city

Recurrent Wheezing in Toronto Recurrent Wheezing in Vancouver Recurrent Wheezing in Montreal Recurrent Wheezing in Calgary Recurrent Wheezing in Edmonton Recurrent Wheezing in Ottawa Recurrent Wheezing in Winnipeg Recurrent Wheezing in Quebec City Recurrent Wheezing in Hamilton Recurrent Wheezing in Kitchener Recurrent Wheezing in London Recurrent Wheezing in Halifax Recurrent Wheezing in New York Recurrent Wheezing in Los Angeles Recurrent Wheezing in Chicago Recurrent Wheezing in Houston